Page 12 of 12 FirstFirst ... 23456789101112
Results 111 to 114 of 114

Thread: Large animal trial for Chondroitinase is underway

  1. #111
    Related to this discussion is http://www.neurosci.cn/news/upload/20141201-986-477.pdf whose article abstract is below. We see discussion/results of ChABC+stem cell testing in UK/China.

    Combination treatment with chondroitinase ABC in spinal cord injury?breaking the barrier
    Rong-Rong Zhao, James W Fawcett
    Brain Repair Centre, University of Cambridge, UK
    Corresponding author: James W Fawcett. E-mail: jf108@cam.ac.uk

    ? Shanghai institutes for Biological Sciences, CAS and Springer-Verlag Berlin Heidelberg 2013

    After spinal cord injury (SCi), re-establishing functional circuitry in the damaged central nervous system (CNS)
    faces multiple challenges including lost tissue volume, insufficient intrinsic growth capacity of adult neurons,
    and the inhibitory environment in the damaged CNS. Several treatment strategies have been developed
    over the past three decades, but successful restoration of sensory and motor functions will probably
    require
    a combination of approaches to address different aspects of the problem. Degradation of the
    chondroitin
    sulfate proteoglycans with the chondroitinase ABC (ChABC) enzyme removes a regeneration
    barrier from the
    glial scar and increases plasticity in the CNS by removing perineuronal nets. its mechanism
    of action does
    not clash or overlap with most of the other treatment strategies, making ChABC an attractive
    candidate as a
    combinational partner with other methods. in this article, we review studies in rat SCi models
    using ChABC
    combined with other treatments including cell implantation, growth factors, myelin-inhibitory
    molecule blockers,
    and ion channel expression. We discuss possible ways to optimize treatment protocols
    for future combinational
    studies. To date, combinational therapies with ChABC have shown synergistic
    effects with several other
    strategies in enhancing functional recovery after SCi. These combinatorial
    approaches can now be developed
    for clinical application.
    Attached Images Attached Images  

  2. #112
    Quote Originally Posted by Pauly1 View Post
    Related to this discussion is http://www.neurosci.cn/news/upload/20141201-986-477.pdf whose article abstract is below. We see discussion/results of ChABC+stem cell testing in UK/China.
    Rong-Rong Zhao was a student working in the Brain Repair Centre, University of Cambridge in the UK under the supervision of James Fawcett back in 2013. He was an author on a few papers during that time period. Literally hundreds of students in various labs throughout the world have worked with rats and Chondroitinase. His more recent papers in 2015 deal with mammary lymph node biopsy and hepatitis B... LINK
    Last edited by GRAMMY; 10-14-2016 at 08:57 PM.

  3. #113
    Grammy thank you for straighten it out. It appears that the dog study is the most advance for C'hase and we all have to wait for the results.

  4. #114

Similar Threads

  1. Anti-Nogo on the go: from animal models to a clinical trial.
    By wildwilly in forum SCI (Animal) Research
    Replies: 0
    Last Post: 10-05-2010, 07:53 PM
  2. Replies: 19
    Last Post: 06-19-2010, 01:06 PM
  3. Replies: 0
    Last Post: 05-12-2010, 04:46 AM
  4. Replies: 0
    Last Post: 04-12-2006, 03:50 AM
  5. Replies: 6
    Last Post: 11-06-2004, 10:11 AM

Tags for this Thread

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •